Roshawn A. Blunt - Aug 2, 2022 Form 4 Insider Report for Reneo Pharmaceuticals, Inc. (RPHM)

Role
Director
Signature
/s/ Jennifer Lam, Attorney-in-Fact
Stock symbol
RPHM
Transactions as of
Aug 2, 2022
Transactions value $
$0
Form type
4
Date filed
8/2/2022, 07:16 PM
Previous filing
Jun 29, 2022
Next filing
Jun 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RPHM Stock Option (right to buy) Award $0 +35K $0.00 35K Aug 2, 2022 Common Stock 35K $2.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the stock option vest and become exercisable in equal monthly installments over a three-year period.